| P2093 | author name string | Julie Magno Zito | |
| P2860 | cites work | Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents | Q47588918 |
| | National trends in the office-based treatment of children, adolescents, and adults with antipsychotics | Q48631822 |
| | Antipsychotics and the risk of type 2 diabetes mellitus in children and youth | Q87291146 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states | Q34171640 |
| | Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents | Q34613195 |
| | Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents | Q37273061 |
| | Second opinions improve ADHD prescribing in a medicaid-insured community population | Q37494228 |
| | Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six. | Q38064342 |
| | Medicaid prior authorization policies for pediatric use of antipsychotic medications | Q38367167 |
| | Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services | Q38905891 |
| | Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens | Q40386583 |
| | Pediatric drug labeling: improving the safety and efficacy of pediatric therapies | Q44556060 |
| P433 | issue | 2 | |
| P304 | page(s) | 555-560 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Health Services Research | Q5690687 |
| P1476 | title | Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL. | |
| P478 | volume | 52 | |